BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

959 related articles for article (PubMed ID: 26632605)

  • 1. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease.
    Egerman MA; Wong JS; Runxia T; Mosoyan G; Chauhan K; Reyes-Bahamonde J; Anandakrishnan N; Wong NJ; Bagiella E; Salem F; Meliambro K; Li H; Azeloglu EU; Coca SG; Campbell KN; Raij L
    FASEB J; 2020 Dec; 34(12):16191-16204. PubMed ID: 33070369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
    Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
    Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinic significance of urinary podocytes in patients with focal segmental glomerulosclerosis].
    Li YH; Huang HC; Liu G; Zhang YK
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):135-8. PubMed ID: 15100729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
    da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
    PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation.
    Matsusaka T; Niimura F; Pastan I; Shintani A; Nishiyama A; Ichikawa I
    Kidney Int; 2014 May; 85(5):1068-77. PubMed ID: 24284520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
    Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
    J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
    Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
    Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
    Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Functional Requirements for Podocalyxin in Immature and Mature Podocytes Reveal Mechanisms of Human Kidney Disease.
    Refaeli I; Hughes MR; Wong AK; Bissonnette MLZ; Roskelley CD; Wayne Vogl A; Barbour SJ; Freedman BS; McNagny KM
    Sci Rep; 2020 Jun; 10(1):9419. PubMed ID: 32523052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
    Raij L; Tian R; Wong JS; He JC; Campbell KN
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
    Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
    BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
    Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
    Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
    Srivastava T; Garola RE; Singh HK
    Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
    Zeng C; Fan Y; Wu J; Shi S; Chen Z; Zhong Y; Zhang C; Zen K; Liu Z
    J Pathol; 2014 Oct; 234(2):203-13. PubMed ID: 24870816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
    Agrawal V; Prasad N; Jain M; Pandey R
    Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.